The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
APOE ε4 allele predicts faster cognitive decline in mild Alzheimer disease
Open accessAbstract
OBJECTIVE: To determine whether APOE epsilon 4 predicts rate of cognitive change in incident and prevalent Alzheimer disease (AD). METHODS: Individuals were recruited from two longitudinal cohort studies-the Washington Heights and Inwood Columbia Aging Project (WHICAP; population-based) and the Predictors Study (clinic-based)--and were followed for an average of 4 years. Three samples of participants diagnosed with AD, with diverse demographic characteristics and baseline cognitive functioning, were studied: 1) 199 (48%) of the incident WHICAP cases; 2) 215 (54%) of the prevalent WHICAP cases; and 3) 156 (71%) of the individuals diagnosed with AD in the Predictors Study. Generalized estimating equations were used to test whether rate of cognitive change, measured using a composite cognitive score in WHICAP and the Mini-Mental State Examination in Predictors, varied as a function of epsilon 4 status in each sample. RESULTS: The presence of at least one epsilon 4 allele was associated with faster cognitive decline in the incident population-based AD group (p = 0.01). Parallel results were produced for the two prevalent dementia samples only when adjusting for disease severity or excluding the most impaired participants from the analyses. CONCLUSION: APOE epsilon 4 may influence rate of cognitive decline most significantly in the earliest stages of Alzheimer disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Our findings are consistent with recent work suggesting that APOE ε4 exerts deleterious effects early in the disease course.(12)”
The cited source says what the claim attributes to it.
In the citing paper
“Some studies suggest that the effect of the ε4 allele on cognitive decline is stronger in the earlier clinical stages of disease and is weaker during the later and more severe clinical stages (Cosentino et al., 2008; Juva et al., 2000).”
From The role of apolipoprotein E in Alzheimer's disease (2009) · cites this paper as Cosentino et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · PubMed · Cited by 21,012
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
Older Adults' Reasons for Using Technology while Aging in Place
Peek, S. T. M., Luijkx, K. G., Rijnaard, M. D., Nieboer, M. E., van der Voort, C. S., Aarts, S., van Hoof, J., Vrijhoef, H. J., & Wouters, E. (2015) · Gerontology · doi:10.1159/000430949 · Cited by 19,852
Sensitivity and False Alarm Rate of a Fall Sensor in Long-Term Fall Detection in the Elderly
Kangas, M., Korpelainen, R., Vikman, I., Nyberg, L., & Jämsä, T. J. (2014) · Gerontology · doi:10.1159/000362720 · Cited by 19,007
Longitudinal data analysis using generalized linear models
LIANG, K.-Y., & ZEGER, S. L. (1986) · Biometrika · doi:10.1093/biomet/73.1.13 · Cited by 18,550
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Cited by
Sorted by citations
Items 101–200 of 216
Mez, J., Cosentino, S., Brickman, A. M., Huey, E. D., Manly, J. J., & Mayeux, R. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065246 · Cited by 25
Self-citationUse of Genetic Variation as Biomarkers for Alzheimer's Disease
Reitz, C., & Mayeux, R. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04945.x · Cited by 24
Jia, J., Gauthier, S. G., Pallotta, S., Ji, Y., Wei, W., Xiao, S., Peng, D., Guo, Q., Wu, L., Chen, S., et al. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.01.007 · Cited by 24
APOE ε4 Is Associated With Exacerbation of Cognitive Decline in Patients With Multiple Sclerosis
Shi, J., Tu, J.-L., Gale, S. D., Baxter, L. C., Vollmer, T. L., Campagnolo, D. I., Tyry, T. M., Zhuang, Y., & Kuniyoshi, S. M. (2011) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e31823380b5 · Cited by 25
Rabipour, S., Rajagopal, S., Yu, E., Pasvanis, S., Lafaille‐Magnan, M., Breitner, J. C. S., & Rajah, M. N. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191292 · Cited by 27
Does apolipoprotein E genotype modify the clinical expression of ALS?
Jawaid, A., Poon, M., Strutt, A. M., Rice, L., McDowell, E. J., Salamone, A. R., Qureshi, S. U., Simpson, E. P., Appel, S. H., York, M. K., et al. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03225.x · Cited by 25
Hou, X., Adeosun, S. O., Zhang, Q., Barlow, B., Brents, M., Zheng, B., & Wang, J. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00207 · Cited by 25
Ali, M., Sung, Y. J., Wang, F., Fernández, M. V., Morris, J. C., Fagan, A. M., Blennow, K., Zetterberg, H., Heslegrave, A., Johansson, P., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0267298 · Cited by 23
APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's Disease
Ayyubova, G. (2023) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666230303114425 · Cited by 23
APOEε4 and slow wave sleep in older adults
Tranah, G. J., Yaffe, K. S., Nievergelt, C. M., Parimi, N., Glymour, M. M., Ensrud, K. E., Cauley, J. A., Ancoli‐Israel, S., Mariani, S., Redline, S. S., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191281 · Cited by 24
Self-citationChen, X. R., Initiative, A. D. N., Shao, Y., & Sadowski, M. J. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210434 · Cited by 22
Mouse models of growth hormone action and aging: A proteomic perspective
Ding, J., Sackmann‐Sala, L., & Kopchick, J. J. (2012) · PROTEOMICS · doi:10.1002/pmic.201200271 · Cited by 20
Zhang, A., Zhao, Q., Xu, D., & Jiang, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-26398-1 · Cited by 20
High Serum Aβ and Vascular Risk Factors in First-Degree Relatives of Alzheimer’s Disease Patients
Abdullah, L. I., Luis, C. A., Paris, D., Ait‐Ghezala, G., Mouzon, B., Allen, E., Parrish, J., Mullan, M. A., Ferguson, S., Wood, M., et al. (2009) · Molecular Medicine · doi:10.2119/molmed.2008.00118 · Cited by 20
Li, P., Quan, W., Wang, Z., Liu, Y., Cai, H., Chen, Y., Wang, Y., Zhang, M., Tian, Z., Zhang, H., et al. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.981451 · Cited by 19
Stone, D. J., Molony, C. M., Suver, C., Schadt, E. E., & Potter, W. Z. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.58 · Cited by 19
Peng, X.-L., Hou, L., Xu, S., Hua, Y., Zhou, S.-J., Zhang, Y., Zheng, Y.-P., Fu, Y.-H., Xu, Q., Zhang, L.-S., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.06.005 · Cited by 19
A New Algorithm for Predicting Time to Disease Endpoints in Alzheimer's Disease Patients
Razlighi, Q. R., Stallard, E., Brandt, J., Blacker, D., Albert, M., Scarmeas, N., Kinosian, B. P., Yashin, A. I., & Stern, Y. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-131142 · Cited by 19
Self-citationCho, H., Kim, Y.-E., Chae, W., Kim, K. W., Kim, J., Kim, H. J., Na, D. L., Ki, C., & Seo, S. W. (2020) · Scientific Reports · doi:10.1038/s41598-020-69603-w · Cited by 19
Genetic Insights into Alzheimer's Disease
Latimer, C. S., Lucot, K. L., Keene, C. D., Cholerton, B., & Montine, T. J. (2021) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-012419-032551 · Cited by 20
The Effect of GBA Mutations and APOE Polymorphisms on Dementia with Lewy Bodies in Ashkenazi Jews
Shiner, T., Mirelman, A., Rosenblum, Y., Kavé, G., Gana‐Weisz, M., Bar‐Shira, A., Goldstein, O., Thaler, A., Gurevich, T., Orr‐Urtreger, A., et al. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-201295 · Cited by 19
Parikh, M., Hynan, L. S., Weiner, M., Lacritz, L. H., Ringe, W. K., & Cullum, C. M. (2014) · The Clinical Neuropsychologist · doi:10.1080/13854046.2014.944937 · Cited by 19
Kim, Y. J., Cho, H., Kim, Y. J., Ki, C., Chung, S. J., Ye, B. S., Kim, H. J., Kim, J., Kim, S. T., Lee, K. H., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141773 · Cited by 18
Kim, B.-H., Nho, K. T., & Lee, J. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.01.021 · Cited by 18
Relationship between a novel learning slope metric and Alzheimer’s disease biomarkers
Hammers, D. B., Suhrie, K. R., Dixon, A. M., Gradwohl, B. D., Archibald, Z. G., King, J. B., Spencer, R. J., Duff, K. M., & Hoffman, J. M. (2021) · Aging Neuropsychology and Cognition · doi:10.1080/13825585.2021.1919984 · Cited by 18
Evidence of emerging BBB changes in mid‐age apolipoprotein E epsilon‐4 carriers
Alruwais, N. M., Rusted, J. M., Tabet, N., & Dowell, N. G. (2022) · Brain and Behavior · doi:10.1002/brb3.2806 · Cited by 17
Yuan, L., Liu, J., Dong, L., Cai, C., Wang, S., Wang, B., & Xiao, R. (2015) · Nutrients · doi:10.3390/nu7105391 · Cited by 17
Empirically Defining Trajectories of Late-Life Cognitive and Functional Decline
Hochstetler, H. M., Initiative, A. D. N., Trzepacz, P. T., Wang, S., Yu, P., Case, M. G., Henley, D. B., Degenhardt, E. K., Leoutsakos, J., & Lyketsos, C. G. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150563 · Cited by 17
Cardiovascular Pharmacogenomics and Cognitive Function in Patients with Schizophrenia
Ward, K. M., Kraal, A. Z., Flowers, S. A., & Ellingrod, V. L. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1968 · Cited by 17
Aspects of Attention Predict Real-World Task Performance in Alzheimer's Disease
Miloyan, B. H., Razani, J., Larco, A., Avila, J. F., & Chung, J. A. (2013) · Applied Neuropsychology Adult · doi:10.1080/09084282.2012.685133 · Cited by 17
Interaction between α-Synuclein and Tau Genotypes and the Progression of Parkinson's Disease
Huang, Y. M., Rowe, D. B., & Halliday, G. M. (2011) · Journal of Parkinson s Disease · doi:10.3233/jpd-2011-11027 · Cited by 17
Modeling Alzheimer's disease progression using the disease system analysis approach
Goméni, R., Simeoni, M., Zvartau-Hind, M. E., Irizarry, M. C., Austin, D. J., & Gold, M. (2011) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2010.12.012 · Cited by 16
A quarter century of advances in the statistical analysis of longitudinal neuropsychological data.
Woodard, J. L. (2017) · Neuropsychology · doi:10.1037/neu0000386 · Cited by 16
Diabetes Mellitus and Amyotrophic Lateral Sclerosis: A Systematic Review
Ferri, L., Ajdinaj, P., Rispoli, M. G., Carrarini, C., Barbone, F., D’Ardes, D., Capasso, M., Muzio, A. D., Cipollone, F., ONOFRJ, M. C., et al. (2021) · Biomolecules · doi:10.3390/biom11060867 · Cited by 17
Pankiewicz, J. E., Lizińczyk, A. M., Franco, L. A., Diaz, J. R., Martá-Ariza, M., & Sadowski, M. J. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01261-z · Cited by 15
Fote, G., Geller, N. R., Reyes-Ortiz, A. M., Thompson, L. M., Steffan, J. S., & Grill, J. D. (2021) · The journal of nutrition health & aging · doi:10.1007/s12603-021-1705-4 · Cited by 16
Monsell, S. E., Liu, D., Weıntraub, S., & Kukull, W. A. (2012) · International Psychogeriatrics · doi:10.1017/s1041610212000452 · Cited by 17
MacDonald, S. W. S., Karlsson, S., Fratiglioni, L., & Bäckman, L. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000325666 · Cited by 15
Alternative Approaches in Gene Discovery and Characterization in Alzheimer’s Disease
Ertekin‐Taner, N., Jager, P. L. D., Yu, L., & Bennett, D. A. (2013) · Current Genetic Medicine Reports · doi:10.1007/s40142-013-0007-5 · Cited by 16
Lee, Y. M., Ha, J., Park, J., Lee, B. D., Moon, E., Chung, Y., Kim, J., Kim, H., Mun, C., Kim, T., et al. (2015) · Psychogeriatrics · doi:10.1111/psyg.12109 · Cited by 15
Genome‐wide association studies identify novel loci in rapidly progressive Alzheimer's disease
Wang, P., Lynn, A., Miskimen, K. L. S., Song, Y. E., Wısnıewskı, T., Cohen, M. L., Appleby, B. S., Safar, J., & Haines, J. L. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13655 · Cited by 14
Genetic Risk Score Predicts Late-Life Cognitive Impairment
Wollam, M. E., Weinstein, A. M., Saxton, J. A., Morrow, L. A., Snitz, B. E., Fowler, N. R., Erickson, B. L. S., Roecklein, K. A., & Erickson, K. I. (2015) · Journal of Aging Research · doi:10.1155/2015/267062 · Cited by 14
Qiu, Q., Shen, L., Jia, L., Wang, Q., Li, F., Li, Y., & Jia, J. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181291 · Cited by 14
Tang, M. E., Blair, J., Bager, C. L., Bay‐Jensen, A., Henriksen, K., Christiansen, C., & Karsdal, M. A. (2020) · Neurology Genetics · doi:10.1212/nxg.0000000000000508 · Cited by 13
Bai, F., Yuan, Y., Shi, Y., & Zhang, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.8100 · Cited by 13
Pharmacogenomics and Treatment for Dementia Induced by Alzheimer‘s Disease
Gupta, M., Kaur, H., Grover, S., & Kukreti, R. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.7.895 · Cited by 13
Link among apolipoprotein E E4, gait, and cognition in neurodegenerative diseases: ONDRI study
Sakurai, R., Pieruccini‐Faria, F., Cornish, B. F., Fraser, J., Binns, M. A., Beaton, D., Dilliott, A. A., Kwan, D. T., Ramirez, J., Tan, B., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.13740 · Cited by 12
The Predictors study: Development and baseline characteristics of the Predictors 3 cohort
Stern, Y., Gu, Y., Cosentino, S., Azar, M., Lawless, S., & Tatarina, O. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.04.004 · Cited by 12
Self-citationMedicaid Contributes Substantial Costs to Dementia Care in an Ethnically Diverse Community
Zhu, C. W., Ornstein, K. A., Cosentino, S., Gu, Y., Andrews, H., & Stern, Y. (2019) · The Journals of Gerontology Series B · doi:10.1093/geronb/gbz108 · Cited by 13
Self-citationRodriguez, F. S., Röhr, S., Pabst, A., Kleineidam, L., Fuchs, Â., Wiese, B., Lühmann, D., Brettschneider, C., Wolfsgruber, S., Pentzek, M., et al. (2020) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5409 · Cited by 12
Suhrie, K. R., Hammers, D. B., Porter, S. M., Dixon, A. M., King, J. B., Anderson, J. S., Duff, K. M., & Hoffman, J. M. (2021) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2021.2023476 · Cited by 12
KIBRA gene polymorphism has no association with verbal or visual episodic memory performance
Franks, K. H., Summers, M. J., & Vickers, J. C. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00270 · Cited by 12
Herden, J. M., Hermann, P., Schmidt, I., Dittmar, K., Canaslan, S., Weglage, L., Nuhn, S., Volpers, C., Schlung, A., Goebel, S., et al. (2023) · Alzheimer s Research & Therapy · doi:10.1186/s13195-023-01249-y · Cited by 11
CR1 is potentially associated with rate of decline in sporadic Alzheimer’s disease
Schmidt, C., Wolff, M., von Ahsen, N., Lange, K., Friede, T., & Zerr, I. (2014) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2014.03.015 · Cited by 12
Mount, D. L., Ashley, A. V., Lah, J. J., Levey, A. I., & Goldstein, F. C. (2009) · Southern Medical Journal · doi:10.1097/smj.0b013e3181b21b82 · Cited by 11
Biomarkers in geriatric psychiatry: searching for the holy grail?
Blumberger, D. M., Daskalakis, Z. J., & Mulsant, B. H. (2008) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328314b763 · Cited by 11
Validation and demonstration of a new comprehensive model of Alzheimer's disease progression
Stern, Y., Stallard, E., Kinosian, B. P., Zhu, C. W., Cosentino, S., Jin, Z., & Gu, Y. (2021) · Alzheimer s & Dementia · doi:10.1002/alz.12336 · Cited by 11
Self-citationKucikova, L., Xiong, X., Reinecke, P., Madden, J., Jackson, E., Tappin, O., Huang, W., Dounavi, M., & Su, L. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102510 · Cited by 10
The role of Apolipoprotein E4 on cognitive impairment in Parkinson’s disease and Parkinsonisms
Rosal, A. E., Martin, S. L., & Strafella, A. P. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1515374 · Cited by 10
Diaz, J. R., Martá-Ariza, M., Khodadadi‐Jamayran, A., Heguy, A., Tsirigos, A., Pankiewicz, J. E., Sullivan, P. M., & Sadowski, M. J. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.845291 · Cited by 11
Mez, J., Cosentino, S., Brickman, A. M., Huey, E. D., & Mayeux, R. P. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130320 · Cited by 10
Self-citationGuo, J., Schupf, N., Cruz, E., Stern, Y., Mayeux, R. P., & Gu, Y. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac011 · Cited by 10
Self-citationZhou, X., Kang, K., & Song, X. (2020) · Statistics in Medicine · doi:10.1002/sim.8513 · Cited by 10
Chen, X. R., Shao, Y., Sadowski, M. J., & Initiative, O. B. O. T. A. D. N. (2023) · Genes · doi:10.3390/genes14040917 · Cited by 9
Li, Y., Kang, M., Sheng, C., Chen, G., Li, T., Wang, J., Cai, Y., Wang, R., & Han, Y. (2020) · Neural Plasticity · doi:10.1155/2020/9742138 · Cited by 9
Haran, J. P., Barrett, A. M., Lai, Y., Odjidja, S. N., Dutta, P., McGrath, P. M., Samari, I., Romeiro, L., Lopes, A., Bucci, V., et al. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251363549 · Cited by 7
Apoe epsilon4 allele frequency in patients with dementia in different ethnic and geographic groups
Aslan, D., Ercan, F., Aybek, H., & Şahiner, T. (2010) · Cited by 7
Zhu, C. W., Gu, Y., Cosentino, S., Kociolek, A. J., Hernandez, M., & Stern, Y. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230584 · Cited by 6
Self-citationClinical predictors of Alzheimer's disease progression
Hishikawa, N., Fukui, Y., Takemoto, M., Sato, K., Shang, J., Yamashita, T., Ohta, Y., & Abe, K. (2018) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13286 · Cited by 6
Sapkota, S., McFall, G. P., Masellis, M., Dixon, R. A., & Black, S. E. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215068 · Cited by 6
Srisaikaew, P., Chad, J. A., Mahakkanukrauh, P., Anderson, N. D., & Chen, J. J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1049609 · Cited by 7
Wang, N., Liu, Q., Liu, H., Cong, X., Yang, H., Yang, Y., Cao, Y., & Ma, L. (2021) · Journal of Diabetes Research · doi:10.1155/2021/8816996 · Cited by 5
TREM2 coding variants in Slovak Alzheimer's disease patients
Ďurmanová, V., Javor, J., Párnická, Z., Minárik, G., Ocenasova, A., Vašečková, B., Kiralyova, I., Šutovský, S., Petrovič, R., & Shawkatová, I. (2022) · Journal of Integrative Neuroscience · doi:10.31083/j.jin2104105 · Cited by 5
The longitudinal effects of global and regional brain measurements on cognitive abilities
Hosseininasabnajar, F., Kakinami, L., & Initiative, A. D. N. (2025) · Scientific Reports · doi:10.1038/s41598-025-08152-6 · Cited by 4
A semiparametric method for estimating the progression of cognitive decline in dementia
Li, X., Bilen‐Green, C., Farahmand, K., & Langley, L. K. (2018) · IISE Transactions on Healthcare Systems Engineering · doi:10.1080/24725579.2018.1455247 · Cited by 4
Lee, H., Kim, B. H., Lee, E. H., Shin, D., Yoo, H., Seo, S. W., & Kim, J. P. (2024) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2024.11.015 · Cited by 3
The APOE gene and cognitive function in non-demented and Alzheimer's disease patients
Payton, A. (2009) · Reviews in Clinical Gerontology · doi:10.1017/s0959259809990268 · Cited by 3
Study DNA Microarray Gene Expression Data of Alzheimer's Disease by Independent Component Analysis
Kong, W., Mou, X., & Yang, B. (2009) · International Joint Conferences on Bioinformatics, Systems Biology and Intelligent Computing · doi:10.1109/ijcbs.2009.106 · Cited by 3
Yee, A., Tsui, N. B. Y., Kwan, R. Y. C., Leung, A. Y. M., Lai, C. K. Y., Chung, T., Lau, J. Y. N., Fok, M., Dai, D., & Lau, L. T. (2021) · Current Alzheimer Research · doi:10.2174/1567205018666210324111401 · Cited by 3
Situmeang, R., Wahjoepramono, E. J., Kaelan, C., Purba, J. S., Suhadi, B., As’ád, S., Aliah, A., Patellongi, I. J., & Wahid, S. (2016) · Medical Journal of Indonesia · doi:10.13181/mji.v25i1.1255 · Cited by 2
Elevated plasma GFAP levels in MCI link APOE ε4 allele with impaired gait speed
Sakurai, R., Suzuki, H., Fujiwara, Y., Uchida, K., Fujita, K., Nakamura, A., Sakurai, T., & Arai, H. (2025) · GeroScience · doi:10.1007/s11357-025-01955-5 · Cited by 2
MST in the wild: Optimizing the mnemonic similarity task for use in diverse environments
Azer, L., Vanderlip, C. R., Mayer, L. L., Ehlert, L., Sultzer, D. L., Shin, H., & Stark, C. E. L. (2025) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2025.109341 · Cited by 2
Nguyen, S. T., Guo, J., Song, S., Reyes‐Dumeyer, D., Sanchez, D. L., Brickman, A. M., Manly, J. J., Schupf, N., Lantigua, R., Mayeux, R. P., et al. (2024) · Neuroepidemiology · doi:10.1159/000536354 · Cited by 2
Gene polymorphisms of CETP and apolipoprotein E in elderly subjects with cognitive impairment
Niculescu, L. S., Toma, L., Ianas, O., & Sima, A. V. (2012) · Open Life Sciences · doi:10.2478/s11535-012-0042-3 · Cited by 2
Gao, Q., Daunt, P., GIBSON, A. M., & Pither, R. J. (2022) · Journal of Aging Research and Lifestyle · doi:10.14283/jarlife.20221 · Cited by 2
Perturbed Brain Energy Metabolism in Alzheimer’s Disease and Diabetes
Wu, L. (2017) · KU ScholarWorks (University of Kansas) · Cited by 2
Current and Developing Methods for Diagnosing Alzheimer's Disease
Fuller, S. J., Carrigan, N., Sohrabi, H. R., & Martins, R. N. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch3 · Cited by 2
Clinical Genetic Databases: ClinVar, ACMG Clinical Practice Guidelines
Boland, M. R. (2024) · Springer eBooks · doi:10.1007/978-3-031-74383-2_4 · Cited by 1
Cell-type-specific APOE4 cascade across the Alzheimer’s disease continuum
Shostak, D. M., Liang, Z., & Huang, Y. (2026) · Neuron · doi:10.1016/j.neuron.2026.04.024 · Cited by 1
The effect of chicken extract on ERK/CREB signaling is ApoE isoform-dependent
Yong, S. M., Ong, Q.-R., Siew, B. E., & Wong, B. (2014) · Food & Function · doi:10.1039/c4fo00428k · Cited by 1
Parra, M. A. (2009) · OpenGrey (Institut de l'Information Scientifique et Technique)
Risk Factors for Disease Progression in Alzheimer's Disease
Schmidt, C., Wolff, M., Shalash, A., & Zerr, I. (2011) · InTech eBooks · doi:10.5772/20160
Cognitive Impairment and the Dementias
Duara, R., Rodriguez, M. J., Loewenstein, D., Farlow, M. R., Ballard, C. G., Chui, H. C., Segal‐Gidan, F., Perry, D. C., Rosen, H. J., Henry, M. L., et al. (2014) · Wiley eBooks · doi:10.1002/9781118730676.ch9 · Cited by 1
Sian, M., & Lee, T.-S. W. (2013) · InTech eBooks · doi:10.5772/54289
Tarantello, C. (2009) · UPT. Syiah Kuala University Library (Syiah Kuala University)
Genetic Risk Factors for Neurodegenerative Diseases
Inoue, K. (2015) · Springer eBooks · doi:10.1007/978-4-431-54541-5_6
Wang, X. R. (2015) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/27084
PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS DA MOTRICIDADE
Físico, E. D. E. (2014)
Albrecht, M. A., & Foster, J. K. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3777-6_7
Memory decline and Aβ amyloid as markers of neurodegeneration in preclinical Alzheimer's disease
Lim, Y. Y. (2013) · Minerva Access (University of Melbourne)
Metadata
- Authors
- Cosentino, S., Scarmeas, N., Helzner, E., Glymour, M. M., Brandt, J., Albert, M., Blacker, D., & Stern, Y.
- Affiliations
- Columbia University Irving Medical Center (US)
- Venue
- Neurology
- Published
- 2008-05-06
- Volume
- 70
- Issue
- 19_part_2
- Pages
- 1842-1849
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- PMC
- PMC2676693
- OpenAlex
- W1999864873
- Cited by
- 214
- References
- 53
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 8 · 2023: 6 · 2022: 9 · 2021: 23 · 2020: 11 · 2019: 7 · 2018: 11 · 2017: 9 · 2016: 8 · 2015: 13 · 2014: 18 · 2013: 15 · 2012: 11
- FWCI
- 12.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5r01ag007370-30)
- National Institute on Aging (AG00261, Z01AG000732, P01AG007232, R01-AG007370, Z01AG000261, L30 AG026603, T32AG000261)
- National Center for Research Resources (RR 00645, M01RR000645)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Cognitive Abilities and Testing
- Keywords
- APOE ε4, Alzheimer's disease, cognitive decline, genetic risk factors, mild cognitive impairment, disease severity, Mini-Mental State Examination
- MeSH terms
- Aged, Aged, 80 and over, Aging, Alzheimer Disease, Cognition Disorders, DNA Mutational Analysis, Female, Gene Frequency, Genetic Testing, Genotype, Humans, Longitudinal Studies, Male, Memory Disorders, Polymorphism, Genetic, Prospective Studies, Time Factors, Cohort Studies, Disease Progression, Genetic Predisposition to Disease, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review